chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5/19 PM, soreness. 5/20 AM Woke up full body soreness, headache, chills, blurred vision, exhausted, light headed, 4 inch diameter circle around the vaccine site. 5/20 PM Did not want to move, full body soreness, horrible headache, chills, blurred vision, exhausted, light headed, 4 inch diameter circle around the vaccine site. 5/21 AM Tired, temperature fluctuations, headache, extreme sweating, 4 inch diameter circle around the vaccine site. 5/21 PM Started feeling better, mild headache, 4 inch diameter circle around the vaccine site. 5/22 All Day felt pretty good, 4 inch diameter circle around the vaccine site. 5/23 All Day full energy, 4 inch diameter circle around the vaccine site. 5/24, 4 inch diameter circle around the vaccine site.
Diarrhea for 1.5 weeks (as of 6/24); swollen lymph node; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 20-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 15Jun2021 10:15 (at the age of 20-year-old) (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history included eczema and ginger allergy. Concomitant medications included methotrexate (METHOTREXATE) and folic acid (FOLIC ACID) taken for an unspecified indication, start and stop date were not reported. The patient not received other vaccine in four weeks. The patient not had COVID prior vaccination and not tested COVID post vaccination. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 unspecified route of administration on 25May2021 10:15 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. On 15Jun2021, 11:00 the patient experienced diarrhea for 1.5 weeks (as of 6/24) and swollen lymph node. The clinical outcome of the events were not recovered.  Information on the lot/batch number has been requested.
All over swelling, cough, severe pain in injected arm, headache, extreme fatigue (bedridden for the first day after the administration day). Still fatigued, cough is increasing
Patient developed a gout attack that took a week to resolve. Patient states that she has experienced gout in the past, but has not experienced a flare recently. This flare did not present the way her past flares have.
Left upper arm red, hot and swollen larger than golf ball, 24 hours, after DTAP injection.
He developed an urticarial rash on his left arm the night of the vaccines, and it spread down to his left hand the next morning.
Myalgia; Mobility decreased; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Myalgia), MOBILITY DECREASED (Mobility decreased) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Myalgia), MOBILITY DECREASED (Mobility decreased) and PYREXIA (fever). At the time of the report, MYALGIA (Myalgia), MOBILITY DECREASED (Mobility decreased) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a consumer concerned a 26 year old male of unspecified race & ethnicity. Initial information was processed along with additional information received on 30-JUL-2021.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) 1 total, dose was administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-JUL-2021, the patient experienced sore throat, cough, loss of taste and possibly a fever. On the same day, he was tested positive for covid-19 infection (suspected covid-19 infection and suspected clinical vaccination failure).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated: 90000187910. The suspected product has been confirmed to be not voided (meet criteria) in investigation result. based on the evaluation/investigation performed.; Sender's Comments: V0:20210800428-JANSSEN COVID-19 VACCINE Ad26.COV2.S- Suspected clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS.
About an hour after DTaP, IPV, and Prevnar, she started throwing up, had a fever, and then got cold and clammy. She has been dry heaving the rest of the day. She was seen in doctor's office again this evening and she is lethargic, clammy and cold. She is very dehydrated. Doctor admitted her to the hospital for further evaluation.
Information has been received from an x-ray technician concerning 2 unspecified patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 26-OCT-2016, the two patients were respectively vaccinated with a dose of improperly stored GARDASIL 9 (lot # M013636, expiration date 15-FEB-2018), dose and route unspecified. The vaccines were stored at 30 F for 9 hours. Data logger was involved in the case. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a Licensed Practical Nurse. The nurse reported that ROTATEQ, GARDASIL, RECOMBIVAX HB and VAQTA were exposed to 20 hours outside of range with a minimum temperature of -1.5 centigrade(C). She also stated that they were exposed to temperatures of 9C for 3 hours and 1C for 3 hours and 10 minutes. The temperature excursion could not be supported. Nurse stated that she was unsure whether or not any of the unsupported doses were administered. Additional information has been requested.
heart palpitations starting 3 days after receiving vaccine; This is a spontaneous report from a contactable Nurse reporting for self.  A 43-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly on 18Dec2020 08:45 as a single dose (Dose 1), right arm (age at vaccination 42-years old) for COVID-19 immunization. The patient is not pregnant and did not receive any other vaccine in the 4 weeks prior to the COVID-19 vaccine. Medical history included diabetes mellitus, drug hypersensitivity, and allergies sulfa.  the patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included omeprazole (PRILOSEC), aripiprazole (ABILIFY), zolpidem tartrate (AMBIEN), famciclovir (FAMVIR), semaglutide (OZEMPIC), and cetirizine hydrochloride (ZYRTEC). On 21Dec2020 at 16:00, the patient experienced heart palpitations starting 3 days after receiving vaccine. The event was reported as non-serious. No treatment was received for the event.  The palpitations were resolving. The patient wasn't COVID tested post-vaccination.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Rash Narrative: dose 1: hard bump day 1-2; rash on day 7. day 2 muscle aches
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown ages and genders. She reported that ROTATEQ, PNEUMOVAX 23 (MARRS# 1406USA005479) and GARDASIL (MARRS# 1406USA004040) were exposed to temperatures outside of recommended range at 30.6F for 36 hours. She stated that the exposure occurred on 23-MAY-2014, and that since then, the unspecified number of patients had received doses of all three vaccine (lot# and dose not reported). M-M-R II was involved. But M-M-R II did not go out of temperature range in this case. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This case was considered medically important (OMIC). Information regarding Prevnar was received from a consumer regarding his male son who received a fourth dose of Prevnar on an unspecified date. The reporter indicated his son has some developmental delays. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was not provided. Concomitant medications were not reported. On an unspecified date the patient received the fourth dose of Prevnar. The reporter indicated the child has some developmental delays. The patient's outcome is unknown. No additional information was available at the time of this report.
Thrombocytopenia  AKI (acute kidney injury)  Neutropenic fever  C. difficile colitis Hypotension, unspecified hypotension type Sepsis
The day after the vaccines were given the child developed a fever between 103-105F. The child continued to have fever for 8 days, but on 5/3/04 was diagnosed with otitis media.
A couple of hours after vaccines, developed hives on torso, left arm and fever. Fever resolved on 4/30/21. Hives increased over 2 days then began to subside. Low appetite, pruritis, malaise as well. No cough, nasal congestion, sore throat, diarrhea.
pt recv vax 23MAY95 & 5JUN95 devel a vesicular rash; also a few papular type lesions; low grade temp; 14JUN95 examined D/T h/a, t101, nuchal rigidity; lab testing revealed AST & ALT inc 3x nl; pt hosp;
stuffy nose; sinuses; headaches; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (stuffy nose), SINUSITIS (sinuses) and HEADACHE (headaches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (stuffy nose), SINUSITIS (sinuses) and HEADACHE (headaches). At the time of the report, NASAL CONGESTION (stuffy nose), SINUSITIS (sinuses) and HEADACHE (headaches) had resolved.            No concomitant product information was reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-060910 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Adverse event outcome changed from Unknown to Recovered.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060910:1st Dose
48 hours after vaccination the patient had a severe erythematous rash over his entire body sparing only his face and mucous membranes. It blanched but not raised. It was extremely itchy but without sob, fever, joint pain, facial swelling, trouble talking or swallowing
Headache, Myalgia, Fever, NauseaVomiging, INJECTION SITE PAIN Narrative:
1/7 vaccination  1/8th Evening, I had a flare up. I felt like I was having fever and chills. Nauseous. It took about 2 1/2 weeks for my body to recover. I was feeling so sick. My boss had turned out COVID+. I had COVID test 1/10/2021; negative.  I was put on Neuroval and mobic.  Sent back to PT for 4 weeks longer because the pain was so bad.
One week after getting injection my arm at injection site had red circular rash with diameter close to size of a lime. Itching, redness, slight swelling. Applied over the counter hydrocortisone cream to help with itching and tea tree oil twice the weekend after rash appeared. Today rash is improving.
Tested positive 8/23/22 while resident of LTC. Received Paxlovid. Admitted for A-fib, and urinary retention.
Moderna COVID-19 Vaccine Swelling, Itching, Redness, Soreness,  injection site warm to touch. OTC Benadryl
Admitted to medical center 8/25/2021 on the COVID unit. Moved to ICU on 9/4 and intubated. Extubated on 9/12 and expired
This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age and ethnicity started to receive PREVNAR, via an unspecified route of administration from May2015 at 1 DF, single. Medical history included allergic to Sodium Benzoate and Potassium Sorbate and these were commonly used fruit preservatives from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced bad reaction (unspecified) on May2015 with outcome of unknown. The action taken in response to the event for PREVNAR was not applicable. No follow up attempts possible. No further information expected.
Fever, sore arm, lethargy, heart palpitations that lasted two weeks, and just had blood work done and my blood pressure, platelets and MCH and MCV were higher than normal.
I noticed two weeks after the vaccine the sound in my left ear sound muffled, tenney, louder ringing. The low amount of tinnitus had worsened and I was unable to hear of that ear.
This spontaneous report was received from a healthcare professional and refers to unspecified number of patients of unknown age or gender. The patients' medical histories and concurrent conditions were not reported. On unspecified dates in 2016, starting on or after 25-FEB-2016, the patients were vaccinated with improperly stored doses of VARIVAX route of administration was not reported (Lot # L034366, expiration date 08-SEP-2017; Lot # L041204, expiration date 20-OCT-2017; Lot # L048462, expiration date 02-DEC-2017). The doses were stored on a temperature of 0.59 degrees C by a time frame of 72 hours and 44 minutes. No adverse effects were reported. Additional information has been requested.
2 nights after received vaccine, first noticed injection site is hard and red all around it.  Finally, Tues April 13, hardness is gone and area around the site is only slightly red.
Pt recvd vax @ 430PM 3OCT91 had t104 R & had a convuls & 2nd convuls @ 10PM tkane by rescue squad to hosp; released @ MN;
the pain was shooting down to his heart; severe pain in his left shoulder after that second dose; injection site pain; pain is around his arms/going on the top of his legs; back and wraps down to the heart; major pain up around his shoulders and around the back of neck; I have stomach problems, I am collapsed stomach; This is a spontaneous report from a contactable consumer (patient). This 55-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) in his left arm on 05Apr2021 at single dose for COVID-19 immunisation. Medical history included Arthritis, Sinus problem, Asthma, Bipolar disorder. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 on unspecified date at age of 55 years old for COVID-19 immunisation. The patient experienced injection site pain, severe pain in his left shoulder after that second dose. Some major pain up around his shoulders and around the back of neck, his left side was worst. He said that the pain was shooting down to his heart. So he went to the hospital because he thought it was something to the heart. They tested him, they evaluated him but they ruled out anything that has to do with the heart. They checked his heart, he had a cardiac catheterization, and was ruled out, everything came out negative.  So, he just got out of hospital and was still developing the pain and it's on his left side, it's on his right side (as reported). He called all his doctors, they had no answers for him, now he was still in a lot of pain in both of shoulders like he was saying his left side was still the worst, and it has not gone away and the pain is still shooting down around his heart and shooting down around the back of neck and now it's going on the top of his legs.  He went to the bone doctor and he was getting an MRI done, because the doctors said nothing was torn in his arms or tissues. He stated the pain was around his arms, back and wraps down to the heart. He was in dire pain, 8.5/10 and had a feeling of it was related to the vaccine. He clarified the pain was in both shoulders and the left side was worse and that was the side he had his shot on.  Patient stated he had stomach problems, he was collapsed stomach. The outcome of events was unknown.   Information on the lot/batch number has been requested.
Patient experienced extreme redness and swelling to outer and inner arm. Inner arm had a sack-like fluid buildup, possibly in lymph system, but was mostly reduced by the time they reported it to this Rph. Very painful, red, sore, came with excessive fever and headache. Patient will be reporting to MD's office in case cellulitis is suspected and/or antibiotics recommended. Patient experienced this within 12 hours after administration of vaccine by the following morning.
Had a headache; mild itchiness.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non- pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EN6203) via an unspecified route of administration in the Left arm on 11Mar2021 at 15:30 (at the age of 61 years) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, environmental allergies. Concomitant medications included losartan (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN), coq10 (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was tested for COVID-19. On 11Mar2021 at 16:00, the patient experienced headache and had mild itchiness. The headache was for a day but itchiness continued. On 19Mar2021, the patient underwent nasal swab test and result was unknown. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events headache was resolved on 12Mar2021 and itchiness was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Right-sided pleural effusion, PE and decreasing renal function resulting in ICU admission.
Initial report received from a vaccine provider on 24 October 2013. A 78 years old female patient, medical history and concomitant medications were not reported, had received a dose of FLUZONE HD (Lot number U4715AA, route and site of vaccination was left deltoid), on 11 September 2013. On 11 September 2013, after receiving vaccine, the patient experienced baseball sized diameter, rash around injection site that lasted for 3 days. Corrective treatment included ice compresses and BENADRYL. Last year, the patient had FLUVIRIN. Event was recovered at the time of this report. Documents held by sender: none.
Sugars high (400+) since flu shot date and complaining of a headache, 2 days later. Referred to Endocrinologist.
Eye blinking throughout the day. No associated symptoms. From January 15, 2015 and continued currently. Referred to neurology.
Shingrix (Late 2nd dose); This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Shingrix (Late 2nd dose)). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 05-JUN-2023 The case was received via web form. The reporter asked if they need to restart the series or just get the second shot. It had been over 2 years since the first shot. The Vaccine Administration Facility was the same as Primary Reporter. No more information that the one provided. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Around end of April, I started running fever. I was having increased allergy type respiratory systems and a lot of fatigue. The doctor ruled out COVID, the flu and a bunch of other things. She decided it was a sinus infection and I did a round of antibiotics. It did not markedly improve - but those symptoms slowly started getting better. I am no longer feverish and the congestion has gone to normal amount of what I normally feel with allergies Then in early May, as the fever was wearing off, I started to get Vertigo - feeling unbalanced and have a lot of fatigue - episodes of extreme fatigue. In May, I was put on Prednisone for a week to resolve the dizziness but it did not.  Video-nystomaghrophy - turned out with results as  balance is fine and everything is fine but I'm still experiencing the symptoms - not a problem with the inner ear.  Ordered a brain MRI - waiting on insurance approval  to find out why I'm having the feeling of unsteadiness.
felt like she was going to pass out; felt nausea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient received BNT162b2 (BNT162B2), on 03Nov2021 as dose 2 (booster), single (Lot number: FG3527) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Primary aldosteronism" (unspecified if ongoing); "Bilateral adrenal hyperplasia" (unspecified if ongoing), notes: Bilateral adrenal hyperplasia. The patient's family history included: "Primary aldosteronism" (unspecified if ongoing), notes: Mother. There were no concomitant medications. Past drug history included: Eplerenone, reaction(s): "renal insufficiency", notes: About a year ago; Eplerenone, reaction(s): "was not able to urinate/ was not able to pee for like a month", notes: About a year ago; Eplerenone, reaction(s): "terrible back pain", notes: About a year ago; Eplerenone, reaction(s): "urine was extra dark", notes: About a year ago. Vaccination history included: janssen shot (First Dose:, Lot: 1805018, Route: Injection in the left arm), administration date: 24Mar2021, when the patient was 58-year-old, for Covid-19 immunization, reaction(s): "sick for 2 full weeks". The following information was reported: LOSS OF CONSCIOUSNESS (medically significant) with onset 03Nov2021, outcome "recovered" (03Nov2021), described as "felt like she was going to pass out"; NAUSEA (non-serious) with onset 03Nov2021, outcome "recovered" (03Nov2021), described as "felt nausea". Therapeutic measures were taken as a result of loss of consciousness, nausea. She was not safe to drive home. She said that she felt better after 15 minutes. She got coconut water and crackers and waited for close to a hour and then was fine after that.